Table 3. CVD risk in relation to baseline variables in the DPS and FINRISK studies.

	DPS study				FINRISK study
	Univariate HR (95% CI)	p	Adj. HR (95% CI)	p	Univariate HR (95% CI)	p	Adj. HR (95% CI)	p
Age	1.34 (1.09–1.63)	0.004			1.57 (1.40–1.75)	<0.001
Sex (1 men, 0 women)	2.64 (1.72–4.07)	<0.001			1.90 (1.55–2.34)	<0.001
Smoking (1 yes, 0 no)	2.55 (1.36–4.81)	0.004			1.48 (1.17–1.87)	0.001
BMI	0.82 (0.64–1.05)	0.110	0.93 (0.72–1.20)	0.576	1.42 (1.30–1.55)	<0.001	1.40 (1.27–1.55)	<0.001
Waist	1.15 (0.89–1.49)	0.288	1.06 (0.80–1.41)	0.683	1.59 (1.44–1.76)	<0.001	1.48 (1.31–1.68)	<0.001
Total cholesterol	0.93 (0.72–1.20)	0.560	0.92 (0.70–1.20)	0.535	1.17 (1.06–1.29)	0.002	1.11 (1.00–1.23)	0.051
Triglycerides	1.46 (1.12–1.89)	0.005	1.44 (1.11–1.86)	0.006	1.31 (1.19–1.43)	<0.001	1.22 (1.09–1.36)	0.001
HDL cholesterol	0.60 (0.44–0.83)	0.002	0.65 (0.47–0.89)	0.007	0.75 (0.67–0.84)	<0.001	0.84 (0.75–1.95)	0.005
Systolic blood pressure	1.27 (1.04–1.55)	0.020	1.19 (0.94–1.52)	0.145	1.46 (1.34–1.59)	<0.001	1.31 (1.19–1.45)	<0.001
Diastolic blood pressure	1.13 (0.90–1.43)	0.287	1.07 (0.84–1.36)	0.598	1.35 (1.23–1.49)	<0.001	1.28 (1.16–1.42)	<0.001
Fasting glucose	1.30 (0.96–1.77)	0.089	1.24 (0.91–1.68)	0.176	1.35 (1.24–1.47)	<0.001	1.28 (1.17–1.40)	<0.001
2-h glucose	1.28 (0.88–1.86)	0.198	1.35 (0.95–1.91)	0.099	1.32 (1.18–1.48)	<0.001	1.25 (1.11–1.41)	<0.001
Lipid medication (1 yes, 0 no)	1.13 (0.37–3.51)	0.829	1.08 (0.38–3.12)	0.884	1.97 (1.94–4.11)	0.070	1.72 (0.82–3.62)	0.153
Blood pressure medication (1 yes, 0 no)	1.82 (1.16–2.84)	0.009	1.80 (1.12–2.89)	0.015	2.33 (1.83–2.97)	<0.001	2.11 (1.65–2.71)	<0.001

Univariate HR: Each of the variables listed, respectively, is included in a model alone.

Adj. HR: Each of the variables listed, respectively, is included in a model together with age, sex and smoking.

Excluding individuals who had CVD before participation to the study. For continuous variables, the hazard ratio is given per 1 standard deviation unit.